Skip to main content
Top
Published in: Osteoporosis International 2/2003

01-02-2003 | Original Article

Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England

Authors: D. H. Solomon, M. T. Connelly, C. J. Rosen, B. Dawson-Hughes, D. P. Kiel, S. L. Greenspan, E. S. Leib, M. Holick, A. H. Miguel, J. S. Finkelstein

Published in: Osteoporosis International | Issue 2/2003

Login to get access

Abstract

Large population-based surveys have shown that approximately 30% of people over age 65 years have osteoporosis and that 17% of the population over 65 years will sustain a fracture during their lifetime. Many people with osteoporosis are never being evaluated even though effective treatments are available. We examined why primary care physicians order few bone mineral density scans. We conducted a cross-sectional survey of primary care physicians practicing in any of the six New England states. Target physician specialties included internal medicine, general practitioners/family physicians, and obstetrician-gynecologists who had a facsimile number listed with the American Medical Association. Demographics, practice characteristics, use of bone densitometry, and attitudes regarding osteoporosis, bone densitometry and health maintenance were assessed by questionnaire. Twelve percent (n=494) of the physicians responded to the questionnaire. Respondents were similar to non-respondents with respect to years of practice, training and geographical state, though they were more likely to be female (p≤0.05). Respondents had a mean age of 51 years, and 51% were trained in internal medicine, 25% in general practice/family practice and 24% in obstetrics-gynecology. The mean number of self-reported bone densitometry referrals per month was 10±11, and 25% of respondents reported that they referred fewer than 4 patients per month. In adjusted logistic models, factors significantly associated with referring fewer than 4 patients per month were: training in internal medicine (odds ratio (OR) 2.0, 95% confidence interval (CI) 1.0–3.9) or general practice/family practice (OR 2.6, 95% CI 1.3–5.2) versus obstetrics-gynecology; practicing in an urban setting (OR 2.5, 95% CI 1.3–4.9) or rural/small town setting (OR 2.2, 95% CI 1.2–4.1) versus a suburban setting; spending less than 50% of professional time in patient care (OR 4.0, 95% CI 1.7–9.5); seeing the lowest proportion of postmenopausal women (OR 2.5., 95% CI 1.2–5.3); the belief that calcium and vitamin D are adequate to treat osteoporosis (OR 2.1, 95% CI 1.0–4.5); and the belief that osteoporosis treatment should not be based on bone density results (OR 3.2, 95% CI 1.7–6.1). Potentially modifiable physician beliefs and a number of practice characteristics are associated with low referral rates for bone densitometry. Educational strategies aimed at improving the use of bone density testing should consider these factors.
Literature
1.
go back to reference Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254–9.PubMed Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254–9.PubMed
2.
go back to reference Kanis JA, WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 1994;4:369–81. Kanis JA, WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 1994;4:369–81.
3.
go back to reference Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670–6.PubMed Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670–6.PubMed
4.
go back to reference Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial. JAMA 1998;280:2077–82.PubMed Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial. JAMA 1998;280:2077–82.PubMed
5.
go back to reference Reginster JY, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83–91.PubMed Reginster JY, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83–91.PubMed
6.
go back to reference Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641–7.PubMed Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641–7.PubMed
7.
go back to reference Chesnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 2000;109:267–76.CrossRefPubMed Chesnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 2000;109:267–76.CrossRefPubMed
8.
go back to reference Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434–41.PubMed Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434–41.PubMed
9.
go back to reference Phillipov G, Mos E, Scinto S, Phillips PJ. Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry. Osteoporos Int 1997;7:162–4.PubMed Phillipov G, Mos E, Scinto S, Phillips PJ. Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry. Osteoporos Int 1997;7:162–4.PubMed
10.
go back to reference Silverman SL, Greenwald M, Klein RA, Drinkwater BL. Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol 1997;89:321–5.PubMed Silverman SL, Greenwald M, Klein RA, Drinkwater BL. Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol 1997;89:321–5.PubMed
11.
go back to reference Rubin SM, Cummings SR. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990–5.PubMed Rubin SM, Cummings SR. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990–5.PubMed
12.
go back to reference Marci CD, Viechnicki MB, Greenspan SL. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int 2000;66:113–8.PubMed Marci CD, Viechnicki MB, Greenspan SL. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int 2000;66:113–8.PubMed
13.
go back to reference Solomon CG, Connelly MT, Collins K, Okamura K, Seely EW. Provider characteristics: impact on bone density utilization at a health maintenance organization. Menopause 2000;7:391–4.PubMed Solomon CG, Connelly MT, Collins K, Okamura K, Seely EW. Provider characteristics: impact on bone density utilization at a health maintenance organization. Menopause 2000;7:391–4.PubMed
14.
go back to reference Sheehan J, Mohamed F, Reilly M, Perry IJ. Secondary prevention following fractured neck of femur: a survey of orthopedic surgeons practice. Irish Med J 2000;93:105–7. Sheehan J, Mohamed F, Reilly M, Perry IJ. Secondary prevention following fractured neck of femur: a survey of orthopedic surgeons practice. Irish Med J 2000;93:105–7.
15.
go back to reference Schrager S, Kausch T, Bobula JA. Osteoporosis risk assessment by family practice faculty and residents: a chart review. West Med J 1999;98:34–6. Schrager S, Kausch T, Bobula JA. Osteoporosis risk assessment by family practice faculty and residents: a chart review. West Med J 1999;98:34–6.
16.
go back to reference Hajcsar EE, Hawker G, Bogoch ER. Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J 2000;163:819–22. Hajcsar EE, Hawker G, Bogoch ER. Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J 2000;163:819–22.
17.
go back to reference Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001;285:320–3.PubMed Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001;285:320–3.PubMed
18.
go back to reference Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo UB, Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int 1993;52:269–72.PubMed Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo UB, Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int 1993;52:269–72.PubMed
19.
go back to reference American Medical Association Master File. Chicago, IL: AMA, 2000. American Medical Association Master File. Chicago, IL: AMA, 2000.
20.
go back to reference Hosmer DW, Lemeshow S. Applied logistic regression, 2nd ed. New York: Wiley, 2000:162. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd ed. New York: Wiley, 2000:162.
21.
go back to reference SAS Institute, Inc. SAS software, changes and updates through release 6.11. Cary, NC: SAS, 1996. SAS Institute, Inc. SAS software, changes and updates through release 6.11. Cary, NC: SAS, 1996.
22.
go back to reference Torgerson DJ, Thomas RE, Campbell MK, Reid DM. Randomized trial of osteoporosis screening: use of hormone replacement therapy and quality of life results. Arch Intern Med 1997;157:2121–5.PubMed Torgerson DJ, Thomas RE, Campbell MK, Reid DM. Randomized trial of osteoporosis screening: use of hormone replacement therapy and quality of life results. Arch Intern Med 1997;157:2121–5.PubMed
23.
go back to reference Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynecol 1992;99:325–8. Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynecol 1992;99:325–8.
24.
go back to reference Rozenberg S, Kroll M, Vandromme J, Paesmans M, Ham H. Effect of bone density evaluation on hormone replacement therapy prescription. Maturitas 1996;24:57–61.CrossRefPubMed Rozenberg S, Kroll M, Vandromme J, Paesmans M, Ham H. Effect of bone density evaluation on hormone replacement therapy prescription. Maturitas 1996;24:57–61.CrossRefPubMed
25.
go back to reference Torgerson DJ, Donaldson D, Russell IT, Reid DM. Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol 1995;59:57–60.CrossRef Torgerson DJ, Donaldson D, Russell IT, Reid DM. Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol 1995;59:57–60.CrossRef
26.
go back to reference Jones G, Scott F. Low bone mass in premenopausal parous women: identification and the effect of an information and bone density feedback program. J Clin Densitom 1999;2:109–15.PubMed Jones G, Scott F. Low bone mass in premenopausal parous women: identification and the effect of an information and bone density feedback program. J Clin Densitom 1999;2:109–15.PubMed
27.
go back to reference Jamal SA, Ridout R, Chase C, Fielding L, Rubin LA, Hawker GA. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res 1999;14:2143–9.PubMed Jamal SA, Ridout R, Chase C, Fielding L, Rubin LA, Hawker GA. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res 1999;14:2143–9.PubMed
28.
go back to reference Davis D, O'Brien MAT, Freemantle N, Wolf FM, Mamanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health outcomes? JAMA 1999;282:867–74.PubMed Davis D, O'Brien MAT, Freemantle N, Wolf FM, Mamanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health outcomes? JAMA 1999;282:867–74.PubMed
29.
go back to reference Oxman AD, Thomson MA, David DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153:1423–31. Oxman AD, Thomson MA, David DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153:1423–31.
30.
go back to reference Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA 1990;263:549–56.PubMed Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA 1990;263:549–56.PubMed
31.
go back to reference Werner P, Vered I. Management of osteoporosis: a survey of Israeli physicians' knowledge and attitudes. Isr Med Assoc J 2000;2:361–4.PubMed Werner P, Vered I. Management of osteoporosis: a survey of Israeli physicians' knowledge and attitudes. Isr Med Assoc J 2000;2:361–4.PubMed
32.
go back to reference Stock JL, Waud CE, Coderre JA, et al. Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial. Ann Intern Med 1998;128:996–9.PubMed Stock JL, Waud CE, Coderre JA, et al. Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial. Ann Intern Med 1998;128:996–9.PubMed
Metadata
Title
Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England
Authors
D. H. Solomon
M. T. Connelly
C. J. Rosen
B. Dawson-Hughes
D. P. Kiel
S. L. Greenspan
E. S. Leib
M. Holick
A. H. Miguel
J. S. Finkelstein
Publication date
01-02-2003
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 2/2003
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-002-1326-7

Other articles of this Issue 2/2003

Osteoporosis International 2/2003 Go to the issue